Latest News

 Filter by Provider

B2B travel services company Global Business Travel (NYSE:GBTG) fell short of the market’s revenue expectations in Q1 CY2025 as sales only rose 1.8% year on year to $621 million. On the other hand, the company expects next quarter’s revenue to be around $625 million, close to analysts’ estimates. Its non-GAAP profit of $0.16 per share was 6.6% below analysts’ consensus estimates.

(BPT) - Summer is nearly here, and travelers everywhere are dreaming of the journeys they'll take with friends and family. But there's one aspect of road trip planning that often goes overlooked, and ironically, it's the only part of the vehicle that touches the road: tires.

Cruise and exploration company Lindblad Expeditions (NASDAQ:LIND) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 17% year on year to $179.7 million. The company’s full-year revenue guidance of $725 million at the midpoint came in 2.1% above analysts’ estimates. Its non-GAAP profit of $0.03 per share was significantly above analysts’ consensus estimates.

After completing the significant corrective wave (II) near the $1.88 level, XRP/USD initiated a new bullish Elliott wave cycle.

Animal health company Zoetis (NYSE:ZTS) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 1.4% year on year to $2.22 billion. The company’s full-year revenue guidance of $9.5 billion at the midpoint came in 1.8% above analysts’ estimates. Its non-GAAP profit of $1.48 per share was 5.8% above analysts’ consensus estimates.

Upon closing of the deal, 23andMe will be operated as a wholly owned direct or indirect unit of Regeneron and will continue operations as a personal genomics service.

Tesla stock is up 24% in May.

The deal between AMD and Sanmina also includes a contingent payment of up to $450 million based on future performance.

Healthcare services provider AdaptHealth Corp. (NASDAQ:AHCO) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 1.8% year on year to $777.9 million. On the other hand, the company’s full-year revenue guidance of $3.25 billion at the midpoint came in 0.5% below analysts’ estimates. Its non-GAAP profit of $0.03 per share was in line with analysts’ consensus estimates.

The acquirer says it will continue 23andMe's consumer genome testing services. It acquired a number of programs, including the biobank.

Integrated packaging solutions provider Sealed Air Corporation (NYSE:SEE) announced better-than-expected revenue in Q1 CY2025, but sales fell by 4.3% year on year to $1.27 billion. The company expects the full year’s revenue to be around $5.3 billion, close to analysts’ estimates. Its non-GAAP profit of $0.81 per share was 20.9% above analysts’ consensus estimates.

Global hospitality company Marriott (NASDAQ:MAR) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 4.8% year on year to $6.26 billion. Its non-GAAP profit of $2.32 per share was 3.1% above analysts’ consensus estimates.

Solar energy systems company Shoals (NASDAQ:SHLS) announced better-than-expected revenue in Q1 CY2025, but sales fell by 11.5% year on year to $80.36 million. Guidance for next quarter’s revenue was better than expected at $105 million at the midpoint, 0.9% above analysts’ estimates. Its non-GAAP profit of $0.03 per share was in line with analysts’ consensus estimates.

Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 1.1% year on year to $233.4 million. On the other hand, next quarter’s revenue guidance of $235 million was less impressive, coming in 2.4% below analysts’ estimates. Its non-GAAP profit of $0.74 per share was 9.9% above analysts’ consensus estimates.

LIFEMD (NASDAQ:LFMD) meets Minervini’s Trend Template with strong technicals and high-growth fundamentals, making it a stock to watch for momentum investors.

Ethereum may have found the support, so we should be aware of a bullish reversal and bigger recovery from technical and Elliott wave perspective.

Electric vehicle charging company EVgo (NASDAQ:EVGO) announced better-than-expected revenue in Q1 CY2025, with sales up 36.5% year on year to $75.29 million. The company’s full-year revenue guidance of $360 million at the midpoint came in 2.3% above analysts’ estimates. Its non-GAAP loss of $0.08 per share was 30.8% above analysts’ consensus estimates.

Clinical research company IQVIA (NYSE: IQV) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 2.5% year on year to $3.83 billion. The company’s full-year revenue guidance of $16.2 billion at the midpoint came in 2.1% above analysts’ estimates. Its non-GAAP profit of $2.70 per share was 2.6% above analysts’ consensus estimates.

Viking Cruises' Q1 earnings are early Tuesday. Royal Caribbean works toward entry.

The S&P 500 has staged a V-shaped recovery, moving to a striking distance near the all-time highs, but the same cannot be said for the US dollar.

Cloud computing provider DigitalOcean (NYSE: DOCN) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 14.1% year on year to $210.7 million. The company expects next quarter’s revenue to be around $216.5 million, close to analysts’ estimates. Its non-GAAP profit of $0.56 per share was 25.8% above analysts’ consensus estimates.

Private label food company TreeHouse Foods (NYSE:THS) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 3.6% year on year to $792 million. The company expects next quarter’s revenue to be around $792.5 million, coming in 0.5% above analysts’ estimates. Its non-GAAP profit of $0.03 per share was significantly above analysts’ consensus estimates.

Clothing company Kontoor Brands (NYSE:KTB) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 1.3% year on year to $622.9 million. The company’s full-year revenue guidance of $3.08 billion at the midpoint came in 16.7% above analysts’ estimates. Its non-GAAP profit of $1.20 per share was 3.1% above analysts’ consensus estimates.

Battery and lighting company Energizer (NYSE:ENR) missed Wall Street’s revenue expectations in Q1 CY2025, with sales flat year on year at $662.9 million. Next quarter’s revenue guidance of $694.4 million underwhelmed, coming in 1.2% below analysts’ estimates. Its non-GAAP profit of $0.67 per share was in line with analysts’ consensus estimates.

TXNM Energy, Inc. (NYSE: TXNM) will be acquired by Blackstone Infrastructure for $61.25 per share in cash, representing a 23.0% premium. Total enterprise value is $11.5 billion, with no new debt expected. Transaction to close in second half of 2026.

GRINDR INC (NYSE:GRND) meets Minervini’s Trend Template with strong technicals and high revenue growth, making it a candidate for momentum and growth investors.

Moody's downgraded US credit rating from Aaa to Aa1, triggering concerns of a 10% market correction. But history has shown dips are buying opportunities.

How to trade the SPY and top tech stocks using technical analysis today, on a light economic calendar.

The Nasdaq 100 Index has a distinct seasonal pattern that has favored the final two weeks of May over the last decade.

Precision measurement and sensing technologies provider Vishay Precision (NYSE:VPG) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 11.2% year on year to $71.74 million. Next quarter’s revenue guidance of $73 million underwhelmed, coming in 3.6% below analysts’ estimates. Its non-GAAP profit of $0.04 per share was 42.9% below analysts’ consensus estimates.

Healthcare tech company Premier (NASDAQ:PINC) reported Q1 CY2025 results topping the market’s revenue expectations, but sales fell by 8.9% year on year to $261.4 million. On the other hand, the company’s full-year revenue guidance of $975 million at the midpoint came in 1.2% below analysts’ estimates. Its non-GAAP profit of $0.44 per share was 45% above analysts’ consensus estimates.

Stay updated with the S&P500 stocks that are on the move in today's pre-market session.

Healthcare tech company Omnicell (NASDAQ:OMCL) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 9.6% year on year to $269.7 million. On the other hand, next quarter’s revenue guidance of $275 million was less impressive, coming in 0.7% below analysts’ estimates. Its non-GAAP profit of $0.26 per share was 27.1% above analysts’ consensus estimates.

Industrial technology solutions provider EnPro Industries (NYSE:NPO) announced better-than-expected revenue in Q1 CY2025, with sales up 6.1% year on year to $273.2 million. On the other hand, the company’s full-year revenue guidance of $0.04 at the midpoint came in 100% below analysts’ estimates. Its non-GAAP profit of $1.90 per share was 14% above analysts’ consensus estimates.

Aurinia Pharmaceuticals (AUPH) meets Louis Navellier’s growth criteria with strong earnings surprises, accelerating revenue, and improving margins. A solid pick for growth-focused investors.

GTBP announces completion of dosing in Cohort 1 and start of dosing in Cohort 2 of Phase 1 trial for GTB-3650, showing potential for NK cell expansion and increased immunologic activity. Detailed results to be released in 2025. GTBP stock up 0.90%.

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.